Sabra Healthcare REIT (NASDAQ:SBRA – Free Report) had its price objective boosted by Wells Fargo & Company from $21.00 to $23.00 in a report issued on Monday morning,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the real estate investment trust’s stock.
A number of other research firms also recently commented on SBRA. Raymond James Financial upgraded Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a research note on Thursday, August 6th. Citizens Jmp upped their price objective on Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a “market outperform” rating in a research note on Wednesday, July 22nd. Weiss Ratings upgraded Sabra Healthcare REIT from a “hold (c)” rating to a “buy (b-)” rating in a research note on Tuesday, November 3rd. UBS Group increased their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a “neutral” rating in a report on Wednesday, November 11th. Finally, Citigroup reaffirmed a “market outperform” rating on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $21.92.
Read Our Latest Stock Analysis on Sabra Healthcare REIT
Sabra Healthcare REIT Trading Up 1.8%
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last announced its quarterly earnings data on Monday, November 2nd. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.05). The company had revenue of $249.57 million for the quarter, compared to analyst estimates of $236.64 million. Sabra Healthcare REIT had a return on equity of 2.55% and a net margin of 7.78%. Sabra Healthcare REIT’s revenue was up 31.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.38 earnings per share. As a group, research analysts expect that Sabra Healthcare REIT will post 1.52 EPS for the current fiscal year.
Sabra Healthcare REIT Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Monday, November 30th. Shareholders of record on Friday, November 13th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 5.8%. The ex-dividend date is Friday, November 13th. Sabra Healthcare REIT’s payout ratio is 428.57%.
Insiders Place Their Bets
In other news, CEO Richard K. Matros sold 200,000 shares of the firm’s stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $20.83, for a total transaction of $4,166,000.00. Following the transaction, the chief executive officer directly owned 1,657,686 shares of the company’s stock, valued at approximately $34,529,599.38. This trade represents a 10.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Foster sold 10,000 shares of the firm’s stock in a transaction on Wednesday, November 11th. The shares were sold at an average price of $20.98, for a total value of $209,800.00. Following the transaction, the director directly owned 72,834 shares in the company, valued at $1,528,057.32. This trade represents a 12.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 1.09% of the company’s stock.
Institutional Investors Weigh In On Sabra Healthcare REIT
Institutional investors have recently bought and sold shares of the stock. Rush Island Management LP acquired a new position in shares of Sabra Healthcare REIT in the 1st quarter worth approximately $30,735,000. William Blair Investment Management LLC bought a new stake in shares of Sabra Healthcare REIT in the 3rd quarter worth approximately $16,545,000. Russell Investments Group Ltd. raised its holdings in shares of Sabra Healthcare REIT by 70.2% in the 3rd quarter. Russell Investments Group Ltd. now owns 1,856,730 shares of the real estate investment trust’s stock worth $36,615,000 after purchasing an additional 765,527 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of Sabra Healthcare REIT by 161.0% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 926,972 shares of the real estate investment trust’s stock worth $18,280,000 after purchasing an additional 571,743 shares in the last quarter. Finally, BROOKFIELD Corp ON acquired a new stake in Sabra Healthcare REIT during the first quarter valued at approximately $9,710,000. Institutional investors and hedge funds own 99.40% of the company’s stock.
About Sabra Healthcare REIT
Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in properties used to provide healthcare and senior living services. Its portfolio includes skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals. Sabra generally leases its properties to healthcare and senior living operators, providing real estate that supports their services. The company’s properties are located in the United States and Canada.
Further Reading
- Five stocks we like better than Sabra Healthcare REIT
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
